IMAX (IMAX) Joins Russell Defensive Indexes, Is The 18% Undervalued View Still Convincing?

IMAX Corporation

IMAX Corporation

IMAX

0.00

IMAX stock: what index inclusion might mean for investors

IMAX (IMAX) was recently added to both the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index, a move that can draw fresh attention as index trackers adjust their holdings.

This kind of index inclusion often prompts mechanical buying from funds that mirror these benchmarks. This can change the daily trading profile of IMAX stock and put its fundamentals in front of a wider investor base.

At a share price of US$38.50, IMAX has a 1 day share price return of 2.72% and a year to date share price return of 6.89%. Its 1 year total shareholder return of 46.39% and 3 year total shareholder return of 125.41% point to momentum that has built over time, with the recent index additions likely contributing to the latest move.

If you want to see what else is attracting fresh attention around market themes like this, it is a good time to scan 19 top founder-led companies

After a sharp run in IMAX and fresh attention from its new index slots, the real focus now is whether the current valuation still compensates you for the risks, or if the recent move has already done most of the work.

Most Popular Narrative: 17.8% Undervalued

IMAX's most followed narrative pegs fair value at $46.82 per share versus the last close at $38.50, putting valuation opinions under a clear spotlight.

Rapid acceleration of new system installations and a replenishing, geographically diverse backlog, driven by consumer demand for premium, differentiated out-of-home entertainment, positions IMAX for continued growth in both top-line revenue and recurring cash flows as its global footprint expands, especially in high-per-screen-average markets like North America, Japan, and Australia.

Want to see what is sitting behind that backlog story and revenue runway? The core of this narrative is how earnings, margins, and future valuation multiples are expected to evolve together, and the assumptions that need to hold for IMAX at $46.82 to make sense.

Result: Fair Value of $46.82 (UNDERVALUED)

However, the IMAX narrative could be challenged if at home entertainment keeps pulling audiences away from cinemas or if blockbuster release schedules become less reliable than analysts expect.

Another view on IMAX valuation

The community narrative frames IMAX as 17.8% undervalued based on future earnings power. Yet the current P/E of 57.6x stands well above both the US Entertainment industry at 22.1x and peers at 55.4x, as well as an estimated fair ratio of 25.8x. That gap points to a richer pricing that could compress if expectations cool. The key question is which signal you view as more informative.

For a closer look at what this richer pricing might imply in practice, run through the detailed breakdown in the See what the numbers say about this price — find out in our valuation breakdown.

NYSE:IMAX P/E Ratio as at Jul 2026
NYSE:IMAX P/E Ratio as at Jul 2026

Next Steps

Given the mixed signals around IMAX's valuation and narrative, it makes sense to check the underlying data yourself and move quickly to form your own view. You can start with the 4 key rewards and 1 important warning sign.

Looking for more IMAX sized investment ideas?

If you stop with IMAX, you might miss other stocks that fit your style. Use the Simply Wall Street Screener to widen your opportunity set confidently.

  • Target income first and scan for businesses with steady cash flows using the 9 dividend fortresses.
  • Hunt for potential bargains by filtering companies that combine quality fundamentals with attractive pricing through the 44 high quality undervalued stocks.
  • Prioritize resilience by focusing on companies that show robust finances in the solid balance sheet and fundamentals stocks screener (47 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.